Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/20020
Title: The emerging role of miRNAs in combined cancer therapy
Authors: Yu, HW
Cho, WC
Keywords: Chemotherapy
Combined cancer therapy
Immunotherapy
MicroRNA
Radiotherapy
Issue Date: 2015
Publisher: Ashley Publications Ltd
Source: Expert opinion on biological therapy, 2015, v. 15, no. 7, p. 923-925 How to cite?
Journal: Expert opinion on biological therapy 
Abstract: MicroRNAs (miRNAs) control physiological and fundamental processes in cellular development and differentiation by modulating the expression of their target genes. They have been found to participate in cell transformation and multiplication by functioning as oncomiRs and tumor suppressors in diverse cancers. Introduction of antisense miRNAs (antagomiRs) into primary cells such as immune cells by lipofection, viral vectors or electroporation can achieve the specific silencing of individual miRNAs. Therefore, harnessing miRNAs may lead to promising cancer therapeutics. There is emerging evidence demonstrating the involvement of miRNAs in combined cancer therapies, including chemotherapy, radiotherapy and immunotherapy combining with miRNA therapy.
URI: http://hdl.handle.net/10397/20020
ISSN: 1471-2598
DOI: 10.1517/14712598.2015.1030390
Appears in Collections:Journal/Magazine Article

Access
View full-text via PolyU eLinks SFX Query
Show full item record

SCOPUSTM   
Citations

12
Last Week
1
Last month
0
Citations as of Dec 5, 2018

WEB OF SCIENCETM
Citations

12
Last Week
0
Last month
0
Citations as of Dec 17, 2018

Page view(s)

58
Last Week
1
Last month
Citations as of Dec 16, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.